Clinical utility of targeted gene enrichment and sequencing technique in the diagnosis of adult hereditary spherocytosis
- PMID: 31807509
- PMCID: PMC6861754
- DOI: 10.21037/atm.2019.09.163
Clinical utility of targeted gene enrichment and sequencing technique in the diagnosis of adult hereditary spherocytosis
Erratum in
-
Erratum to clinical utility of targeted gene enrichment and sequencing technique in the diagnosis of adult hereditary spherocytosis.Ann Transl Med. 2019 Dec;7(Suppl 8):S391. doi: 10.21037/atm.2019.12.120. Ann Transl Med. 2019. PMID: 32016109 Free PMC article.
Abstract
Background: The present study aimed to use the targeted capture and sequencing technique to diagnose adult hereditary spherocytosis (HS). These results were compared with clinical features and laboratory examinations to explore the diagnosis of HS.
Methods: Whole blood and clinical data from ten patients with HS were collected. Genomic DNA was extracted, and a library was prepared. Exomes of patients with ten HS-related genes encoding red cell membrane skeleton protein were captured and sequenced. Bioinformatics analyses were carried out throughout the 1000 Genomes Project, ExAC, dbSNP147, and 1000 Normal Han Population databases.
Results: Gene mutations were found in 9 out of 10 cases of HS. Our data validation showed 90% specificity. Three types of gene mutations were found, including 6 cases of SPTB, 3 cases of ANK1, and 2 cases of SLC4A1. There were 4 mutation forms, including nonsense mutation, missense mutation, shear mutation, and code shift mutation, all of which were new, heterozygous mutations. These variations were predicted to be pathogenic in four databases.
Conclusions: Our data demonstrate that targeted gene enrichment and sequencing methods were an efficient tool for determining genetic etiologies of red blood cell (RBC) membrane disorders and can facilitate accurate diagnosis and genetic counseling. They are also in good agreement with the clinical results.
Keywords: ANK1; Hereditary spherocytosis (HS); SLC4A1; SPTB; targeted capture.
2019 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Comment in
-
How will next generation sequencing (NGS) improve the diagnosis of congenital hemolytic anemia?Ann Transl Med. 2020 Mar;8(6):268. doi: 10.21037/atm.2020.02.151. Ann Transl Med. 2020. PMID: 32355712 Free PMC article. No abstract available.
References
-
- King MJ, Behrens J, Rogers C, et al. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000;111:924-33. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous